Removal of a gadolinium based contrast agent by a novel sorbent hemoperfusion in a chronic kidney disease (CKD) rodent model

Gadolinium based contrast agents (GBCAs) have been linked to toxicity in patients, regardless of having impaired or normal renal function. Currently, no therapy is considered highly effective for removing gadolinium (Gd) from the body. We propose a new strategy to reduce blood Gd content that facili...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngamcherdtrakul, Worapol, Morry, Jingga, Sangvanich, Thanapon, Reda, Moataz, Bejan, Daniel S., Fryxell, Glen E., Yantasee, Wassana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345740/
https://www.ncbi.nlm.nih.gov/pubmed/30679698
http://dx.doi.org/10.1038/s41598-018-37348-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345740/
https://www.ncbi.nlm.nih.gov/pubmed/30679698
http://dx.doi.org/10.1038/s41598-018-37348-2

Ejemplares similares